Group Walters, 10% Owner, on August 14, 2026, executed a purchase for 4,335,000 shares in Zentalis Pharmaceuticals (ZNTL) for $15,172,500. Following the Form 4 filing with the SEC, Walters has control over a total of 17,844,973 common shares of the company, with 17,844,973 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1725160/000121390026091823/xslF345X05/ownership.xml